These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1886042)

  • 1. FDA inspections in Canada.
    Oliver EA
    J Parenter Sci Technol; 1991; 45(3):142-6. PubMed ID: 1886042
    [No Abstract]   [Full Text] [Related]  

  • 2. EC/FDA joint inspections.
    Nasto B
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688225
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA in the global village.
    Williams RD
    FDA Consum; 1992; 26(6):14-7. PubMed ID: 10119705
    [No Abstract]   [Full Text] [Related]  

  • 4. The outer limits of FDA inspections.
    Scarlett T
    J Parenter Sci Technol; 1991; 45(4):204-8. PubMed ID: 1770416
    [No Abstract]   [Full Text] [Related]  

  • 5. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparing for an FDA preapproval inspection.
    Blackmer RA
    Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foreign FDA pre-approval inspections: requirements/preparation.
    Wells M
    PDA J Pharm Sci Technol; 1994; 48(6):330-2. PubMed ID: 7850456
    [No Abstract]   [Full Text] [Related]  

  • 9. Ten steps to ensure a successful preNDA approval inspection.
    Justice RM; Rodriguez JO; Chiasson WJ
    J Parenter Sci Technol; 1993; 47(2):89-92. PubMed ID: 8515350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation--mission completed?
    Sharp J
    J Parenter Sci Technol; 1993; 47(1):2-3. PubMed ID: 8445494
    [No Abstract]   [Full Text] [Related]  

  • 11. Double standards in GMP deduplication row.
    Hodgson J; Fox JL
    Nat Biotechnol; 1996 Dec; 14(13):1647-8. PubMed ID: 9634839
    [No Abstract]   [Full Text] [Related]  

  • 12. Outsourcing challenges FDA to strengthen oversight abroad.
    Torres C
    Nat Med; 2010 Feb; 16(2):139. PubMed ID: 20134448
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
    Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
    Woo J; Wolfgang S; Batista H
    Clin Pharmacol Ther; 2008 Mar; 83(3):494-7. PubMed ID: 18253142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 17. Public policy implications of cross-border Internet pharmacies.
    Cohen JC
    Manag Care; 2004 Mar; 13(3 Suppl):14-6. PubMed ID: 15074164
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
    Enzi MB
    Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
    [No Abstract]   [Full Text] [Related]  

  • 19. Current regulatory issues regarding parenteral inspections.
    Avallone H
    J Parenter Sci Technol; 1989; 43(1):3-7. PubMed ID: 2926605
    [No Abstract]   [Full Text] [Related]  

  • 20. LyphoMed, FDA reach agreement.
    Wagner M
    Mod Healthc; 1988 May; 18(22):6. PubMed ID: 10287683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.